Crossmark

Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance

Crossref DOI link: https://doi.org/10.1016/j.eururo.2016.08.043

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morlacco, Alessandro

Cheville, John C.

Rangel, Laureano J.

Gearman, Derek J.

Karnes, R. Jeffrey
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2016.08.043

Content Type: article

Copyright: © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.